Recruitment of Rad51 and Rad52 to Short Telomeres Triggers a Mec1-Mediated Hypersensitivity to Double-Stranded DNA Breaks in Senescent Budding Yeast by Lin, Yi-Hsuan et al.
Recruitment of Rad51 and Rad52 to Short Telomeres
Triggers a Mec1-Mediated Hypersensitivity to Double-
Stranded DNA Breaks in Senescent Budding Yeast
Yi-Hsuan Lin, Chia-Ching Chang, Chui-Wei Wong, Shu-Chun Teng*
Department of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan
Abstract
Telomere maintenance is required for chromosome stability, and telomeres are typically replicated by the action of
telomerase. In both mammalian tumor and yeast cells that lack telomerase, telomeres are maintained by an alternative
recombination mechanism. Here we demonstrated that the budding yeast Saccharomyces cerevisiae type I survivors derived
from telomerase-deficient cells were hypersensitive to DNA damaging agents. Assays to track telomere lengths and drug
sensitivity of telomerase-deficient cells from spore colonies to survivors suggested a correlation between telomere
shortening and bleomycin sensitivity. Our genetic studies demonstrated that this sensitivity depends on Mec1, which
signals checkpoint activation, leading to prolonged cell-cycle arrest in senescent budding yeasts. Moreover, we also
observed that when cells equipped with short telomeres, recruitments of homologous recombination proteins, Rad51 and
Rad52, were reduced at an HO-endonuclease-catalyzed double-strand break (DSB), while their associations were increased
at chromosome ends. These results suggested that the sensitive phenotype may be attributed to the sequestration of repair
proteins to compromised telomeres, thus limiting the repair capacity at bona fide DSB sites.
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Introduction
Telomeres are the specialized DNA-proteins complexes at the
ends of eukaryotic chromosomes that allow intact ends to be
distinguished from broken chromosomes, prevent chromosomes
from end-to-end fusion, degradation, genomic instability and the
associated risk of cancer. In most organisms, telomeric DNA is
composed of a tandem array of short sequences. For example, these
repeats in S. cerevisiae consist of ,350675 bp of duplex TG1–3/
C1–3A tracts. Internal to the TG1–3/C1–3A tracts are two classes of
middle repetitive DNA elements, called X and Y’ [1]. X elements
with heterogeneous sizes ranged from 0.3,3.75 kb exist in all
chromosomes of S. cerevisiae [2], whereas one to four copies of
Y’-long (6.7 kb) or Y’-short (5.2 kb) are found on about two-thirds
of the telomeres. Telomeric DNA forms a heterochromatin
structure with the Rap1p complex [3,4]. Loss of telomeric
protection can lead to the formation of end-to-end fusions, which
directly disrupt the correct structure at telomere termini [5]. In
addition to the inhibition of inappropriate repair responses, fusions
or recombinations, telomeres need to be fully replicated by the
action of telomerase to prevent end-replication problem [6,7,8,9].
In S. cerevisiae, telomerase RNA and reverse transcriptase are
encoded by EST2 and TLC1, respectively. Although the majority
of telomerase-minus S. cerevisiae cells enter cell cycle arrest
eventually following the senescence stage [10,11], survivors arise
through RAD52-dependent homologous recombination (HR).
Most survivors are type I, which have multiple tandem copies of
the subtelomeric Y’ element followed by very short terminal tracts
of TG1–3/CA1–3 DNA [10,12]. In a minor fraction of the survivors
(type II), the lengths of telomere sequence are increased
heterogeneously from several hundred base pairs to 10 kb or
longer (Teng and Zakian, 1999). The generation of type I survivors
depends on the presence of helicase Rad54, Rad51 that acts in
strand invasion, Rad55-Rad57 complex that stabilizes recombi-
nation filament [13], and 59-to-39 exonuclease Exo1 [14]. The
formation of type II survivors, on the other hand, requires MRX
complex (Mre11, Rad50 and Xrs2), Rad59 for strand invasion,
and the Sgs1-Top3 complex, which is involved in the process of
HR [15,16,17,18,19].
Telomere attrition caused by lack of telomerase in S. cerevisiae
has been shown to activate DNA damage checkpoints as they
approach senescence, and this activation is also believed to be
responsible for the premature growth arrest in these strains
[20,21]. The convergence of DNA damage and telomere
checkpoints has also been revealed in mammalian cells
[5,22,23], suggesting that DSBs and compromised telomere
structure both impinge upon the ATM pathway that converges
on a critical p53 nodal point. In the telomerase mutant mouse
model, lack of p53 allows dysfunctional cells to avoid fates
associated with checkpoint activation, including growth arrest and
apoptosis [24,25]. These results indicate that in mammals, as in
yeast, telomere attrition resulting from lack of telomerase or
alterations in telomere structure triggers characteristic DNA
damage-initiated checkpoint. Additionally, not only do short
telomeres share some of the biological and mechanistic features of
DNA damage sites, they also exert effects on cellular response to
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that telomere length correlates with organismal sensitivity to
radiation [26,27]. However it remains an open question of how
the dysfunctional telomeres contribute to DSB sensitivity. Here we
observed that yeast cells with short dysfunctional telomeres
displayed MEC1-dependent hypersensitivity to DSBs and a robust
redistribution of HR proteins from the endogenous DSBs to the
telomeres, providing a molecular aspect of the relationship
between aging and impaired DNA repairing capacity.
Materials and Methods
See the Supplemental Data for additional experimental details.
Strains and plasmids
All the yeast operations were performed by standard methods
[28]. Yeast strains used in the study are listed in Table S1. All
strains constructed in this study were isogenic to YPH501 (MATa/
MATa ura3-52/ura3-52 lys2-801 amber/lys2-801 amber ade2-101
ochre/ade2-101 ochre trp1D63/trp1D63 his3D200/his3D200 leu2-D1/
leu2-D1), BY4743 (MATa/a his3D1/his3D1 leu2D0/leu2D0 LYS2/
lys2D0 met15D0/MET15 ura3D0/ura3D0), AGY673 [29], or
BY4743 (Invitrogen). YPH499 tlc1::LEU2 complemented with
pRS316-TLC1 was described previously [12]. For spotting assays,
the dnl4::KanMX4 and rad59::HIS3 mutants were constructed by
transforming dnl4::KanMX4 and rad59::HIS3 PCR fragments,
respectively, into the YPH499 strain, and were crossed with
YPH500 tlc1::LEU2 to obtain heterozygous diploids. The rad50
mutant and mec1 sml1and tel1 mutants were described as previously
[17,30,31] and were crossed with YPH500 tlc1::LEU2 to obtain
heterozygous diploids. The G418 resistant rad9, rad24, chk1, pds1
and dun1 mutants (Invitrogen) were crossed with the BY4741
tlc1::HIS3 mutant (constructed by PCR-based replacement of the
TLC1 sequence) to obtain heterozygous diploids. The pds1::LEU2
ts mutant was created in BY4742 by using pAY55 plasmid (a kind
gift from Dr. D. Koshland) as previously described [32] and was
crossed with tlc1::HIS3 mutant to obtain heterozygous diploids.
The mrc1::HIS3 was constructed by PCR-based replacement of the
MRC1 ORF in BY4742 and the resulting strain was crossed with
BY4741 tlc1::LEU2 to obtain heterozygous diploids. All heterozy-
gous diploids were sporulated for haploid single, double, or triple
mutants.
For HOcs ChIP analysis, tlc1 mutant was constructed by
transforming AGY67 [29] with the tlc1:: TRP1 PCR fragment
amplified from STY161 (YPH499 tlc1::TRP1) genomic DNA using
TLC1-59 and TLC1-39 as primer pairs. For telomere ChIP
analysis, YPH499 UT strain containing modified chromosome
VII-L was described previously [33], and both wild type and
tlc1::LEU2 spore colonies used in this study were derived from
tetrad dissection of YPH501 UT tlc1::LEU2/TLC1 diploids. For
immunofluorescence assay, the Myc-tagged RAP1 strain was
constructed by double crossing over the chromosomal RAP1 of
YPH499 with a 13Myc PCR fragment from pFA6a-13Myc-
KanMX6 [34]. This strain was transformed with pWJ1213 [35], a
plasmid carrying Rad52-YFP and the HIS3 marker (a kind gift
from Dr. R. Rothstein) and its chromosomal RAD52 was deleted
by PCR-based replacement using a RAD52::URA3 PCR fragment.
The resulted strain was crossed with YPH500 tlc1::LEU2 to obtain
heterozygous diploids and sporulated for YPH499 wild type and
tlc1::LEU2 haploid cells containing KanMX6, HIS3 and URA3
markers.
All type I survivors were confirmed by the telomere restriction
fragment (TRF) assay. All pre-senescent tlc1 mutants used in this
study were derived directly from spore colonies (about 25
generations). Genotype was confirmed by Southern blot, PCR
and/or sequencing analysis. Primer sequences for PCR, real-time
PCR amplification and sequencing are listed in Table S2.
DNA damage sensitivity assays
For spotting assays, log-phase cultures were adjusted to an
OD600 of 0.1 or 1 for type I survivors, and serial five-fold dilutions
were plated on YPD followed by exposure to different tempera-
tures, ionizing radiation (IR), UV light, or YPD containing various
concentrations of glucose, bleomycin (BLM), methyl methanesul-
fonate (MMS), H2O2, or hydroxyurea (HU).
Yeast culture condition, sample preparation, enzyme
digestion, gel electrophoresis, and Southern blot analysis
Each spore colony was inoculated into YEPD and grown at
30uC. Several independent isolates for each genotype were
analyzed. Spore cells were serially diluted into or restreaked onto
YEPD medium. Liquid cultures were generated by inoculating
spore colonies from the tetrad plate into 10 ml of liquid YEPD
medium. Cultures were diluted repeatedly 1:10,000 into fresh
medium at 48 or 72 hours. A solid-plate study was performed by
repeatedly streaking spore colonies from the tetrad plates on
YEPD plates. Genomic DNA preparation and Southern blot
analysis were performed as previously described [31,36]. To
examine the DNA from individual colonies, each colony was
expanded in 2 ml of liquid medium to obtain DNA for Southern
blot analysis. The DNA was digested with XhoI in order to observe
the type I pattern or with a mixture of HaeIII, HinfI, HinpII, and
MspI four-base cutters to observe the type II pattern. A 500-bp
C1–3A fragment was randomly labeled with the Random Prime
Labeling system (Invitrogen) and used in Southern hybridization.
Data shown under ‘‘Results’’ are representative of two or more
experiments from independent spore colonies.
Protein extraction, trichloroacetic acid (TCA) precipitation
and Western blot analysis
Yeast cells were grown overnight at 30uC in 5 ml YEPD
medium and refreshed from OD600=0.2 to OD600=0.5 in 10 ml
of YEPD. Cells were washed with 1 ml of sterile water and
resuspended in 1 ml of cold 0.25 M NaOH/1% 2-mercaptoeth-
anol, followed by incubation on ice for 10 min. Samples were
added with 160 ml of 50% TCA and incubated on ice for
additional 10 min. Cells were pelleted at full spin for 10 min and
then washed with 1 ml of acetone. After air dry, 100 ml of 2x SDS
sample buffer was added to resuspend protein extracts. Western
blot analysis was performed as described [18] using an anti-Rad51
antibody (Santa Cruz sc-33626), an anti-Rad52 antibody (Santa
Cruz sc-50445), or an anti-Pgk1 antibody (Molecular Probes A-
6457) for detection.
Chromatin immunoprecipitation (ChIP)
Yeast cells were grown overnight in 5 ml of YEPD at 30uC,
washed twice with ddH2O, and refreshed to an OD600=0.2 in
100 ml YEP medium with 2% raffinose until mid-log phase
(OD600,0.5). One gram of galactose was then added into 50 ml of
culture, while the other half was remained in YEP medium
containing raffinose. After two hours of incubations at 30uC, cells
were spin down and cross-linked with 1% formaldehyde and ChIP
was conducted as described [37] using polyclonal anti-Rad51 and
anti-Rad52 antibodies or normal rabbit IgG as a control. DNA
was extracted and dissolved in 100 ml of TE. PCR primers specific
to the ASP3 gene (which is on a different chromosome from the
MAT) were included as an internal control. ChIP samples were
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[38], and were normalized to the value of each non-induced
counterpart [29]. Data are expressed as ‘‘relative IP’’ using wild
type as 100% enrichment. To collect samples for telomeric ChIPs,
yeast cells were grown overnight in 5 ml of synthetic complete
medium that lacked uracil at 30uC and refreshed to an
OD600=0.2 in 100 ml of YEPD medium until mid-log phase
(OD600,0.5). Bleomycin was then added into 50 ml of culture to a
final concentration of 7.5 mU/ml for 2 hr at 30uC, while the other
half was remained in YEPD medium without treatment. Data for
Rad proteins binding at telomeric regions were normalized to
input DNA and expressed as the amount of VIIL (telomeric
sequence on the left arm of chromosome VII) over that of DDI2
gene (internal control). Samples were amplified in triplicate to
obtain an average value and ChIPs were repeated at least three
times for each strain.
Immunofluorescence
All experiments were performed in 23uC to allow the YFP
chromophore to form efficiently. Cells were fixed with 4%
formaldehyde and processed for fluorescence microscopy as
descried previously [39]. Rap1 foci were detected by using anti-
Myc monoclonal antibody (9E10, Roche). To stain genomic DNA,
0.3 mg/ml DAPI was added to the mounting solution. All images
were captured at 63-fold magnification using a Plan-Apochromat
663, 1.4 NA objective lens. Cells were mounted and analyzed
under a confocal microscope (Leica TCS SP5, Wetzlar). The
illumination source was a 100-W mercury arc lamp. Images were
acquired and pseudo-colored using Leica LAS AF software. For
each field of cells, 22 images were obtained at 0.2-mm intervals
along the z axis to allow inspection of all focal planes of each cell.
At least 300 cells were counted to determine the percentage of cells
with Rad52-YFP foci. For the percentage of Rad52-YFP foci
colocalized with Rap1-Myc13, we calculated the percentage of
YFP coinciding with anti-Myc signals, rather than the converse.
Three persons independently scored at least 200 cells for 50% or
more overlap of yellow and red traced areas, each of which was
defined as a colocalization.
Results
Type I survivors are hypersensitive to DNA DSBs
To characterize the property of telomerase-minus cells, we first
challenged wild-type, pre-senescent telomerase-minus cells, senes-
cent type I or type II survivors with different stresses. Interestingly,
type I survivors were exquisitely hypersensitive to strand break-
inducing agents, including BLM, MMS, IR, and UV light, but not
to different temperatures, altered glucose concentrations, oxidative
free radical-forming agent H2O2 or replication stress-inducing
drug HU (Figure 1 and data not shown). The reason why type I
cells were more resistant to HU than type II survivors is unclear.
In order to confirm that growth inhibition induced by bleomycin
was not restricted to a single source of type I survivors, we further
tested the sensitivity of 448 type I survivors derived from nine
independent tlc1 spore colonies to bleomycin. After three days of
incubation at 30uC, survival rates of these type I survivors on
YEPD plates containing bleomycin (2 mU/ml) were scored (data
not shown). 55% (248 of 448) of tested type I survivors were able to
grow on plates containing bleomycin, while the rest 45% (200 of
448) were not. To determine if the Y’-short and Y’-long elements
that form the major part of type I telomeres contribute to the
generation of two distinct populations with different bleomycin
sensitivity, genomic DNA of 24 sensitive and 24 resistant type I
survivors was digested with XhoI and subjected to Southern blot
analysis with a Y’ probe. However, no apparent differences in Y’
patterns between the two populations were observed (Figure S1),
suggesting that Y’-long or Y’-short preference did not affect the
bleomycin sensitivity of type I survivors.
All type I survivors are eventually sensitive to bleomycin
following sufficient passages
The results above drove us to quest whether the bleomycin
sensitivity of type I cells was due to epigenetic events which
rendered two interchangeable phenotypes, or constant events
caused by irreversible genetic alterations. To distinguish these, we
passaged both sensitive and resistant populations on solid plates for
up to 12 streaks (240,300 generations) and tested their sensitivity
to bleomycin. At the 12
th streak, virtually all survivors (51/52)
ceased to proliferate on plates containing bleomycin (Figure S2).
This result implies that most of the type I survivors given sufficient
outgrowth are eventually sensitive to bleomycin. Viewed in this
finding, the sensitivity of type I can be regarded as a constant
phenotype rather than a random event. It was notable that
Southern blot analysis of Y’ elements also showed no apparent
differences in the distribution of the two types of Y’ between the
only resistant survivor and other sensitive ones at the 12
th streak
(data not shown).
Sensitive phenotype of type I survivors is attributed to
the inactivation of telomerase
It has been reported previously that progressive telomere
shortening leads to chromosome instability [40]. To test this
possibility that critical genetic aberrations might arise from
telomere attrition and thus contribute to the bleomycin-sensitive
phenotype, the RNA component of telomerase from a CEN-based
plasmid containing TLC1 (pRS316-TLC1) was delivered into type
I cells as well as control strains. As shown in Figure 2A, type I
survivors became resistant to bleomycin after complemented with
a plasmid-borne TLC1, suggesting that the sensitive phenotype of
type I survivors was attributed to the inactivation of telomerase. A
Southern blot analysis on the telomere pattern was also performed
to monitor the change of telomere length in these strains
(Figure 2B). Further measures on the rate of forward mutation
to canavanine resistance (Can
r) also showed no striking difference
in the spontaneous mutation rate in type I survivors compared to
control cells (Figure S3). These results indicate that rather than
permanent genetic mutations, the loss of telomerase is more likely
the major cause of sensitive response of type I survivors to DNA-
damaging agents.
Cells undergone progressive telomere attritions are
susceptible to DSB attack
In order to paint a detailed picture regarding exactly when the
tlc1 mutant becomes DSB-sensitive and what causes this distinct
response between type I and type II survivors to DSBs, we tracked
the change in the response to bleomycin from a tlc1 spore colony
till a survivor. Type I and type II survivors were obtained by
repeatedly restreaking the tlc1 spore colony on solid plates and
continuous dilutions in liquid culture, respectively. Yeast colonies
from each restreak (corresponds to 20–25 generations) or each
dilution (corresponds to 13 generations) were analyzed by spot
assays on YEPD plates with or without bleomycin (Figure 3A), and
the timing of survivor formation was monitored by Southern blot
analysis (Figure 3B).
When the tlc1 mutant was maintained on solid plates, cells
displayed sensitivity to bleomycin from the first streak, and they
showed much lower viability on bleomycin plates for the following
Redistribution of Rad Proteins
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generated at the 3
rd restreak, as it was evident by Southern blot
analysis (Figure 3B, top). Unlike type I survivors, although the tlc1
mutant also displayed sensitivity in the first two dilutions in liquid
culture, increased resistance to bleomycin was observed immedi-
ately after the development of type II survivors (Figure 3A, lower),
in which telomere lengthening occurred rapidly by recombination
of TG1–3 tracts (Figure 3B, lower). Because the major difference
between two subtypes of survivors is the application of distinct
recombination pathways to reconstruct their chromosomal ends,
we speculated that it is the shorter TG1–3 tracts in early senescent
tlc1 mutants and type I survivors that conferred their sensitivity
to DSBs.
Recruitments of Rad51 and Rad52 are reduced at an
internal HO cut site but increased at telomeres in type I
survivors
Previous works have shown that many DNA repair proteins are
often associated with telomeres. We speculated that the titration of
DNA repair proteins to shortened chromosomal ends might
decrease repair capacity at bona fide DSB sites. Since DSBs as the
major cytotoxic lesions caused by bleomycin are preferably
repaired by HR [41], we subsequently examined whether Rad51
and Rad52 were less efficiently recruited to an induced DSB in
type I survivors. We investigated the recruitment of Rad51 and
Rad52 to a single DSB by ChIP. The experimental system is
shown in Figure 4A: a functional URA3 allele containing a copy of
the actin intron as well as the Y–Z junction from the MATa locus,
including the recognition sequence and cleavage site for the HO
endonuclease, was transformed into a yeast strain that has been
deleted of all MAT related sequences and contains an integrated
galactose-inducible HO endonuclease gene. Upon growth in
galactose media, the HO endonuclease created a unique DSB in
the middle of the URA3 gene.
Wild type, tlc1 and type I strains were grown in YEP media with
raffinose as the sole carbon source until mid-log phase. Galactose
was then added to induce expression of the HO endonuclease. At
various times after galactose addition, aliquots were removed and
genomic DNA was isolated to analyze for the formation of a DSB at
the MAT locus using a PCR assay. The induction kinetics showed
that all strains remained only approximately 20,27% of the
original signal after two-hour induction (Figure S4). Figure 4B
shows the quantitative results of ChIPs using a polyclonal antibody
against Rad51 (left) or Rad52 (right). Immunoprecipitated DNA
was analyzed by real-time PCR to detect MAT locus DNA from left
side of the induced DSB (designated as ‘‘HOL’’). PCR primers
Figure 1. Type I survivors are hypersensitive to DNA-damaging agents. To measure the character of telomerase-minus cells, five-fold serial
dilutions of isogenic wild type (WT), pre-senescent tlc1 mutant, type I or type II strains were spotted onto YPD plates containing indicated drugs with
denoted concentrations. The plates were incubated at 30uC for three days before photograph.
doi:10.1371/journal.pone.0008224.g001
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MAT) were included as an internal control. Compared to wild type
cells, type I survivors showed only 8% and 16% in bindings of
Rad51 and Rad52, respectively, to the HO-induced DSB, while the
pre-senescent tlc1 mutant displayed similar results as wild type cells.
To confirm that the reduced bindingsof Rad51 and Rad52 intypeI
survivors was not due to lower protein expression levels, expression
levels of both proteins were compared. As shown in Figure 4C, type
I survivors expressed a higher level of Rad51 than that of wild type,
andapproximatelythesamelevelofRad52asthatofwildtype.This
is consistent with the finding that Rad51 expression is up-regulated
during senescence in genome-wide studies of expression response to
telomere shortening [42,43]. Therefore, it was not the lower protein
expression that caused the decreased bindings of repair proteins to
the HO cut site. To exclude the possibility that the reduced
recruitments of HR proteins in type I survivors is caused by the
different phases which WT and type I cells may be in, we conducted
theChIPexperimentwithbothstrainsarrestedinG2/Mphase,and
similarresultswereobtained (datanotshown).From the data above,
we propose that the sensitive phenotype to DNA-damaging agents
in cells with short telomeres may be resulted from their impaired
ability to recruit sufficient DNA repair proteins to damaged sites.
To determine whether the gathering of repair proteins at short
telomeres perturbed their recruitment to DSBs, the amount of
Rad51 and Rad52 bound at the left telomere of chromosome VII
(VII-L) was examined by ChIP in strains containing the modified
chromosomes (Figure 5A). Since telomeres were constantly subject
to recombinant events upon loss of telomerase and thus were likely
to relocate or lose the sequence designed for quantification, the
maintenance of the URA3 marker in the telomere of type I
survivors were confirmed by Southern blot before ChIP analysis
(data not shown). ChIP samples were quantitated by real-time
PCR. As shown in Figure 5B (left), there was a 3.2-fold enrichment
of telomere sequences in the anit-Rad51 immunoprecipitate of
type I cells, whereas both wild-type and pre-senescent tlc1 mutant
strains showed a 1.9-fold enrichment. Similar results were found
with Rad52 (Figure 5B, right). While the short VII-L telomeric
DNA was enriched 4.3-fold in the anti-Rad52 immunoprecipitate
of type I survivors, there was only 1.5 and 1.6-fold enrichment in
wild-type and pre-senescent tlc1 mutant strains, respectively. As
expected, the two-hour treatment with bleomycin (1.5 mU/ml)
before ChIP samples were collected did not decrease the level of
Rad52 bound to the telomere in type I survivors (data not shown).
However, to exclude the possibility that the higher association of
Rad proteins to the modified telomere in type I cells was attributed
to some artifacts formed during the ChIP procedure, we further
investigated whether these sequestered repair proteins can be
released from telomeres to bona fide DSBs upon subjection to
exogenous DNA damage. Towards this aim, before ChIP samples
were collected, a portion of yeast culture was treated with high
concentration of bleomcyin (7.5 mU/ml) for two hours. As a
result, the bindings of both Rad proteins at VII-L reduced to the
wild-type level in type I cells after treated with bleomycin
(Figure 5B). In contrast, both wild-type and pre-senescent tlc1
mutant strains displayed indistinguishable bindings of Rad
proteins at VII-L before and after bleomycin treatment. All
together, these results demonstrate that sequestration of Rad51
and Rad52 at short telomeres reduces the efficiency of their
recruitments to an induced DSB site and that the mere onset of
telomerase deprivation in pre-senescent tlc1 mutant does not lead
to the same level of biased distribution of Rad proteins as shown in
type I survivors.
To confirm that type I survivors sequester the key repair protein
Rad52 to short telomeres at the cellular level, we investigated the
redistribution of Rad52 in wild-type and type I cells by
immunofluorescence using YFP-marked Rad52 and Myc-tagged
Rap1. Since spontaneous Rad52 foci form mainly at chromosome
breaks during normal DNA replication, to easily obtain signal,
cells were arrested in G1 and then released into S-phase [44]. The
percentage of cells presenting HR foci was determined micro-
scopically. Consistent with the fact that short telomeres require the
recombination protein Rad52 to be rescued, we found that type I
survivors showed higher levels of Rad52 foci compared to WT
cells (Figure 6A). To determine whether the higher level of
spontaneous Rad52 foci formed in type I cells reflects HR proteins
being sequestered at short telomeres, colocalization of Rad52 with
the telomeric DNA-binding protein Rap1 (tagged with Myc) was
investigated. While wild-type strains formed only 9.3% of the
Rad52 foci colocalized with a Rap1 focus, type I cells displayed
more than 20% colocalization prior to bleomycin treatment
(Figure 6B, black bars) and this level of colocalization slightly
decreased when subjected to DSBs (Figure 6B, gray bars). These
results confirm our ChIP data (Figure 5) that HR proteins were
‘‘hyper-recruited’’ to the telomeres in Type I survivors and that
high concentration of bleomycin released HR proteins from their
associated telomeres, even though this redistribution may not be
Figure 2. A CEN-based plasmid containing TLC1 complemented
the sensitive phenotype of type I survivors. (A) Wild-type, pre-
senescent tlc1 mutant, type I or type II strains carrying pRS316 or
pRS316-TLC1 plasmid were five-fold serially diluted and spotted onto
YEPD plates containing bleomycin in various concentrations. (B)
Southern blot analysis of the XhoI-digested genomic DNA isolated
from strains described in panel A probed to detect telomeric sequences.
doi:10.1371/journal.pone.0008224.g002
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PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8224Figure 3. Dynamics of bleomycin response during tlc1 mutant outgrowth. (A) Spot test analysis of serial 5-fold dilutions of the indicated
strains on YEPD or YEPD containing indicated concentration of bleomycin. tlc1 spore colonies were passaged either by restreaking on solid plates
(top) or repeat dilutions in liquid medium (bottom). (B) Southern blot analysis of the XhoI- (top) or four-base cutter (bottom)-digested genomic DNA
isolated from the strains in (A) probed with telomere sequences. The numbers in both panels indicate numbers of restreaking or dilutions. The arrows
in (A) indicate the rise of type I (top) or type II (bottom) survivors.
doi:10.1371/journal.pone.0008224.g003
Figure 4. Recruitments of Rad51 and Rad52 at an HO cut site are reduced in type I survivors. (A) The structure of the URA3 allele on S.
cerevisiae chromosome V for these experiments. The position of various oligonucleotide primers (arrows) used for PCR and real-time PCR are shown.
(B) ChIPs were performed and quantitated by real-time PCR as described in Materials and Methods. Error bars represent standard deviations for at
least three independent experiments and are provided for these strains. Bindings of Rad51 and Rad52 to HOcs in type I cells differed from those in
wild-type in a statistically significant manner (P values =0.0002 and 0.0115, respectively). These differences were not observed when a mock
immunoprecipitation was performed with normal rabbit IgG (data not shown). (C) Rad51 and Rad52 expression levels in these strains were analyzed
by Western blot analysis.
doi:10.1371/journal.pone.0008224.g004
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bleomycin.
The sensitivity of type I cells to bleomycin behaves in a
checkpoint-dependent manner
Previous studies have indicated that the short telomeres cause
cell cycle arrest [20,21,45,46,47], suggesting that compromised
telomeres are recognized as damaged DNAs and are capable of
triggering the DNA repair machinery during an arrest. Several
proteins in the HR pathways and factors involved in the DNA
damage machinery have been reported to associate with the ALT
pathway or to participate in the process when compromised
telomeres are detected as DSBs [31,46,48]. Therefore, we are
interested in whether these genes impinge on the bleomycin
sensitivity of type I survivors.
We first asked whether factors controlling the fate of repair in
telomerase-minus cells contribute to this sensitivity. Both RAD50
and RAD59, which belong to the RAD52 epistasis group, are
required for telomere maintenance in telomerase-minus cells and
are not essential for type I pathway [17,19]. Elimination of RAD50
or RAD59 in type I cells was subjected to spotting assays as
described in Figure 1. As shown in Figure 7, deletion of either
RAD50 or RAD59 slightly increased the sensitivity of type I cells to
bleomycin, whereas abrogation of a major nonhomologous end
joining (NHEJ) component DNL4 resulted in no further pheno-
typic alterations. These data further underline the role of HR
proteins in the sensitivity to DNA damage of type I cells.
Given that we have additionally observed a chronic cell cycle
delay and persistent Rad53 phosphorylation in type I survivors
(Figure S5), spotting assays were performed to investigate if
checkpoint activation (Figure 8A) correlates with type I sensitivity
to bleomycin. Strikingly, ablation of MEC1 greatly enhanced type
I survival rate in response to bleomycin, whereas deletion of TEL1
only mildly promoted its survival (Figure 8B). To ensure that these
results were accompanied with modified checkpoint competence,
the phosphorylated level of Rad53 in various strains was
determined by Western blot analysis. Indeed, the absence of
MEC1 completely abolished persistent checkpoint activation in
type I survivors (Figure S5). Moreover, MEC1 deletion largely
hampered Rad53 phosphorylation induced by bleomycin treat-
ment in type I survivors (Figure S5). Since similar results were not
observed in tel1 deletion mutants, the persistent checkpoint
activation, the associated cell cycle arrest and the bleomycin
sensitivity might be mainly dependent on MEC1. These observa-
tions prompted us to further study if the ablation of MEC1
downstream genes (Figure 8A) surmounts the sensitivity phenotype
of type I cells. As shown in Figure 8B, deletion of RAD9, RAD24,
MRC1, CHK1, DUN1 or PDS1 (partially deleted as a temperature
sensitive mutant, see Materials and Methods) promoted the
proliferation of type I cells on plates containing bleomycin.
Notably, we were unable to determine whether RAD53-deleted
cells display the same effect since the spore colonies were too sick
to survive on YEPD plates during the second restreak and no type
I survivors could be assayed. Altogether, these results indicate that
a Mec1-related checkpoint signal pathway regulates the hyper-
sensitivity to DSBs in cells with short telomeres.
Discussion
The impact of telomere shortening on senescent budding yeast
upon loss of telomerase function is rather difficult to estimate
Figure 5. Sequestration of repair proteins at telomeres in type I survivors. (A) The left arm of chromosome VII-L in YPH499 UT strain was
modified by integration of fragments containing the URA3 and telomeric sequence at the ADH4 locus. Telomeres are represented by hatched ovals;
arrows indicate primers used for real-time PCR. (B) ChIPs were performed and quantitated by real-time PCR as described in Materials and Methods.
Error bars represent standard deviations for at least three independent experiments. Before the addition of bleomycin (black bars), bindings of Rad51
and Rad52 to the VII-L telomere in type I cells differed from those in wild-type in a statistically significant manner (P values =5.36610
28 and 0.010,
respectively), and their bindings to the VII-L telomere was statistically indistinguishable in pre-senescent tlc1 mutant and wild-type strains. In type I
cells, bindings of Rad51 and Rad52 to the VII-L telomere before bleomycin treatment (black bars) differed from those after treatment (gray bars) in a
statistically significant manner (P values =0.0004 and 0.014, respectively). This discrepancy was not observed in both pre-senescent tlc1 mutant and
wild-type strains.
doi:10.1371/journal.pone.0008224.g005
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PLoS ONE | www.plosone.org 7 December 2009 | Volume 4 | Issue 12 | e8224Figure 6. Localization of Rad52 to telomeres in cells with short telomeres. (A) The percentage of cells forming spontaneous Rad52-YFP foci
was scored as described in Materials and Methods. (B) The percentage of Rad52-YFP foci colocalized with Rap1-Myc. Wild-type and type I cells
expressing Rad52-YFP and Myc-tagged Rap1 were arrested in G1 with a-factor for 2.5 hours. Half of the culture was exposed to bleomycin for 30 min
to generate DSBs. Cell treated with or without bleomycin were released into S-phase for 90 min. Before the addition of belomycin, the proportion of
colocalized Rad52 in type I cells differed from that in wild-type in a statistically significant manner (P values =0.019), and in type I cells, the
percentage of colocalization prior to bleomycin treatment (black bars) also differed from that after treatment (gray bars) in a statistically significant
manner (P values =0.0232). Error bars represent standard deviations for at least three independent experiments. (C) Images of representative cells
from the experiment in panel B show colocalization of Rad52 and Rap1 in type I cells. Scale bar, 2 mm. Arrowheads mark selected foci. BF, bright field.
doi:10.1371/journal.pone.0008224.g006
Figure 7. Deletion of RAD50 or RAD59 slightly altered the sensitivity of type I survivors. Exponentially growing cells were five-fold serially
diluted, spotted onto YPD plates containing bleomycin with indicated concentrations and incubated at 30uC for 3 days. TI represents type I survivors
derived from each mutant spore colonies, and all the others are pre-senescent spore colonies.
doi:10.1371/journal.pone.0008224.g007
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within a narrow timeframe. In this study, we observed that type I
survivors are exclusively hypersensitive to DSBs (Figure 1). We
have proved that this phenotype was not caused by some
permanent genetic distortions since it could be complemented
by a plasmid-borne TLC1 and elevated mutation rates were not
detected in type I cells (Figure 2 and S3). We further discovered
that the sensitive response to DSBs is not only restricted to type I
survivors, but also applies to tlc1 senescent cells before any survivor
formation (Figure 3A). Once TG1–3 tracts are lengthened through
the recombination pathway, such as in type II survivors, cells can
be recovered from the DSB-sensitive phenotype (Figure 3A).
Southern blot analysis (Figure 3B) demonstrated that the overall
TG1–3 tracts of senescent tlc1 mutants and type I survivors are
relatively shorter than those of wild type or type II survivor strains.
This indicates a correlation between short telomeres and
ineffective DSB repair.
Our finding of the reduced binding of HR proteins to a single
cut site along with the observation of increased association of HR
proteins with telomeres in type I survivors (Figures 4, 5, and 6)
provides a potential mechanistic basis for the impaired DSB
response in organisms with dysfunctional telomeres. Similar
observations have been proposed in two recent studies [49,50],
both of which reported a robust Rad52 localization with the
telomere in the est2 mutant. Meyer and Bailis [49] have also
demonstrated a correlation between this sequestration of Rad52 to
telomeres in the est2 mutant and reduced localization to an
induced DSB formation. One apparent difference with our results
is that the pre-senescent est2 mutant strain in the Meyer et al.
experiments showed increased binding of Rad52 to the telomere,
Figure 8. Type I sensitivity to bleomycin is in a largely checkpoint-dependent manner. (A) Signaling of MEC1/TEL1-regulated checkpoint
pathway [56]. (B) Exponentially growing cells were five-fold serially diluted and spotted onto YPD plates containing bleomycin with indicated
concentrations. Except for the plates shown in the last panel, which were incubated at 25uC, all of the strains were incubated at 30uC for three days. TI
represents type I survivors derived from each mutant spore, and all the others are pre-senescent spore colonies.
doi:10.1371/journal.pone.0008224.g008
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The discrepancy can be explained by the divergent strain
backgrounds that generate different rates of senescence. Addition-
ally, our ChIP results are consistent with the observation that pre-
senescent tlc1 mutant is not as sensitive as senescent cells or type I
survivors to bleomycin (Figure 3A).
The idea of competition between DNA damage sites has also
been reported elsewhere: the inhibitory effect of NHEJ on the
initiation of DSB resection in G1 phase is able to be suppressed by
four or more DSBs, indicating that some components of NHEJ
may become limiting in the presence of multiple breaks [51].
Because shortened telomeres mimic DSBs, we speculate that DSB
repair proteins, either for HR or NHEJ, might become limiting as
well in the presence of shortened telomeres that resemble DSB
sites.
One surprising finding was that the MEC1 removal leads to a
dramatic increase in the bleomycin resistance in type I survivors
(Figures 8B), indicating that type I sensitivity to bleomycin is
dependent on MEC1. Type I survivors persistently displayed
phosphorylated Rad53 even in the absence of bleomycin and the
bleomycin-induced Rad53 mobility shift was almost abolished in
conjunction with the abrogation of MEC1 gene (Figure S5),
suggesting that type I sensitivity to DSBs might be attributed to the
persistent Mec1-related checkpoint activation. These findings were
quite striking, because checkpoint activation is normally expected
to coincide with improved damage resistance. However, here we
observed that diminished checkpoint activation by deleting MEC1
dramatically promoted bleomycin tolerance of type I survivors.
Nonetheless, similar results have been reported previously [52], as
the abolished Rad53 phosphorylation in mec1 mutants is
suppressed by deletion of MDT1. This improved checkpoint
activation paradoxically worsened bleomycin tolerance compared
to mec1 single mutants. Moreover, Alabert et al. have reported
similar conflicting observations that Mrc1-dependent checkpoint
activation prevents homolgous recombination at DNA DSBs [44].
They proposed that ssDNA exposed at stalled forks is the key
signal to recruit HR machinery and suppress potentially dangerous
HR at DSBs, since ssDNA is already present at the stalled fork and
DSB repair depends on the formation of the 39 ssDNA overhangs.
These findings prompt us to hypothesize that short telomeres
distinguish themselves from DSBs through exposed 39 overhangs
to trigger Mec1-dependent checkpoint activation and thus prevent
HR at DSBs that still need resection. In fact, the idea that Mec1 is
required to recognize signals emanating from short telomeres was
supported by a recent ChIP result showing that Mec1 interacts
physically with critically short telomeres, thereby sensing and
transducing the signal for G2/M cell-cycle arrest [53]. In this
study, even though type I survivor formation seems to be one
major alternative pathway to repair the damage caused by
dysfunctional telomeres, these survivors, nevertheless, resemble the
senescent cells that suffer from a prolonged arrest. This prolonged
arrest indicates an attempt to repair ‘‘chromosomal end damage’’
in type I cells. Combined with the ChIP and IF data, it is tempting
to speculate that in the absence of Mec1, short chromosomal ends
are not properly recognized as DNA damage sites, thereby
becoming less competitive for DNA repair proteins that are
normally recruited to bona-fide DSBs (Figure S6). Further
investigations are needed to clarify this possibility. Altogether, this
study suggests that the translocation of Rad51, Rad52, and likely
other repair factors to telomeres contributes to the Mec1-
dependent hypersensitivity to DSBs in telomerase deficient cells.
Studies of the role of telomerase in the maintenance of genome
integrity in mammalian cells have provided insight into the
molecular aspects in aging and cancer, and in particular, epithelial
carcinogenesis [54]. A growing number of evidence also supports
that various pathways of DNA repair become less efficient in aged
cells [55]. The work presented here suggests another mechanism
by which aged organisms may suffer from increased rates of
unrepaired DNA damage and its concomitant risk of cancer.
Careful considerations of the ways in which effective therapeutics
are designed may help for the treatment and prevention in the
aged.
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Supporting Information
Figure S1 Patterns of Y’ telomeres are indistinguishable between
sensitive and resistant type I survivors. Equal amounts of the XhoI-
digested genomic DNA isolated from wild-type and type I
survivors of tlc1 mutants (6
th streak) were loaded for Southern
blot analysis, using a Y’ fragment as a probe [1]. BLM
R indicates
strains that are resistant to bleomycin at 2 mU/ml and BLM
S
indicates sensitive strains. Arrows denote the positions of Y’-long
and Y’-short elements. Marker sizes are indicated at the left (Kb).
Found at: doi:10.1371/journal.pone.0008224.s001 (4.25 MB TIF)
Figure S2 Survival rates of early type I survivors on bleomycin
plates.Survivalrateswere measuredasthenumberofviablepatches
on YEPD containing 2 mU/ml of bleomycin over that on YEPD
without bleomycin. Type I survivors from nine independent spore
colonies were examined. A total of 447 survivors were scored for the
6
th streak, 52 for the 9
th and 52 for the 12
th streaks, respectively.
Found at: doi:10.1371/journal.pone.0008224.s002 (1.06 MB TIF)
Figure S3 Measurement of mutation rates. (A) Assay for
mutation rate measurement. Strains harbor a can1 mutation are
resistant to canavanine. (B) To measure the rate of forward
mutation to canavanine resistance (Can
r), at least six yeast cultures
were started from single colonies and grown to stationary phase in
10 ml liquid YEPD medium. Cells were plated with appropriate
dilutions onto complete medium containing L-canavanine
(60 mg/ml) and lacking arginine for Can
r mutant count, and
onto complete medium lacking arginine for viable count. The pol2-
4 (STY1609) mutant, previously reported to express a mutator
phenotype [2], was used as a positive control. YIpBI (kindly
provided by Dr. A. Sugino) was used to create the pol2-4 mutant in
YPH499 background by the method previously described [3].
Mutation rates were determined by the method of the median [4].
Found at: doi:10.1371/journal.pone.0008224.s003 (0.98 MB TIF)
Figure S4 Kinetics of DSB induction at the HO cut site.
Galactose (2%, w/v) was added to cells in mid-log phase in order
to induce HO endonuclease expression. Genomic DNA was
purified at various time points, and PCR was performed using
primers RAG513 and RAG 515 that flank the HO cut site (HOcs)
from 114 bp CEN distal of the HOcs to 946 bp CEN proximal.
The DSB was detected as a loss of PCR product. Primers specific
to the ASP3 gene were included in the PCR as a control. DSB
bands were quantitated by the ImageQuant software, normalized
to the ASP3 bands, and indicated as the percentage of starting
signal (‘‘% remaining product’’) at the bottom of the panel.
Found at: doi:10.1371/journal.pone.0008224.s004 (2.53 MB TIF)
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bleomycin of type I survivors is mainly dependent on Mec1.
Rad53 phosphorylation was assayed by Western blot analysis.
Proteins were prepared from strains in Figure 8B (top two panels)
using trichloroacetic acid precipitation as described in Materials
and Methods. Samples were separated on 7% SDS-polyacryl-
amide gels and transferred to nitrocellulose membranes. The
membranes were incubated with a 1:1000 dilution of anti-Rad53
antibody (gift of J. Diffley), followed by incubation with the
secondary antibody. Membranes were developed using ECL
chemiluminescence (GE) and exposed to autoradiographic film. It
should be noted that Rad53 was partially phosphorylated in type I
survivors before bleomycin treatment (5 mU/ml, 3 hours) and
that was suppressed by MEC1 deletion.
Found at: doi:10.1371/journal.pone.0008224.s005 (2.79 MB TIF)
Figure S6 The distribution of Rad proteins in cells with short
telomeres. Rad51 (red triangles) and Rad52 (blue ovals) are
sequestered at chromosome ends in cells with short telomeres.
Found at: doi:10.1371/journal.pone.0008224.s006 (2.50 MB TIF)
Table S1 Strains used in this study
Found at: doi:10.1371/journal.pone.0008224.s007 (0.09 MB
DOC)
Table S2 Oligonucleotide primers
Found at: doi:10.1371/journal.pone.0008224.s008 (0.04 MB
DOC)
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